These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37877393)

  • 1. [Rapamycin mediated caspase 9 homodimerization to safeguard human pluripotent stem cell therapy].
    Yang Y; Liu Y; Chen M; Li S; Lu X; He Y; Zhang K; Zou Q
    Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):4098-4107. PubMed ID: 37877393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rapamycin-Activated Caspase 9-Based Suicide Gene.
    Stavrou M; Philip B; Traynor-White C; Davis CG; Onuoha S; Cordoba S; Thomas S; Pule M
    Mol Ther; 2018 May; 26(5):1266-1276. PubMed ID: 29661681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.
    Bedel A; Beliveau F; Lamrissi-Garcia I; Rousseau B; Moranvillier I; Rucheton B; Guyonnet-Dupérat V; Cardinaud B; de Verneuil H; Moreau-Gaudry F; Dabernat S
    Stem Cells Transl Med; 2017 Feb; 6(2):382-393. PubMed ID: 28191782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the AAVS1 Site by CRISPR/Cas9 with an Inducible Transgene Cassette for the Neuronal Differentiation of Human Pluripotent Stem Cells.
    Gu J; Rollo B; Sumer H; Cromer B
    Methods Mol Biol; 2022; 2495():99-114. PubMed ID: 35696030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
    Karbassi E; Padgett R; Bertero A; Reinecke H; Klaiman JM; Yang X; Hauschka SD; Murry CE
    Cell Mol Life Sci; 2024 Feb; 81(1):95. PubMed ID: 38372898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells.
    Nishimura T; Xu H; Iwasaki M; Karigane D; Saavedra B; Takahashi Y; Suchy FP; Monobe S; Martin RM; Ohtaka M; Nakanishi M; Burrows SR; Cleary ML; Majeti R; Shibuya A; Nakauchi H
    Gene Ther; 2019 Nov; 27(10-11):525-534. PubMed ID: 32704085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing in Human Induced Pluripotent Stem Cells (hiPSCs).
    Higo S; Hikoso S; Miyagawa S; Sakata Y
    Methods Mol Biol; 2021; 2320():235-245. PubMed ID: 34302662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Transgene Silencing of Myeloid-Specific Promoters in the
    Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
    Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation.
    Husa AM; Strobl MR; Strajeriu A; Wieser M; Strehl S; Fortschegger K
    Stem Cells Dev; 2018 Oct; 27(19):1376-1384. PubMed ID: 30009677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas-Mediated Knock-in of Genetically Encoded Fluorescent Biosensors into the AAVS1 Locus of Human-Induced Pluripotent Stem Cells.
    Stellon D; Tran MTN; Talbot J; Chear S; Khalid MKNM; Pébay A; Vickers JC; King AE; Hewitt AW; Cook AL
    Methods Mol Biol; 2022; 2549():379-398. PubMed ID: 34505269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a CAG-EGFP tagged cell line (KSCBi017-A-2) from human induced pluripotent stem cells using CRISPR/Cas9.
    Han HW; Im YS; Kim YO; Kwak S; Cho SJ
    Stem Cell Res; 2024 Mar; 75():103303. PubMed ID: 38211411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells.
    Tay FC; Tan WK; Goh SL; Ramachandra CJ; Lau CH; Zhu H; Chen C; Du S; Phang RZ; Shahbazi M; Fan W; Wang S
    J Gene Med; 2013 Oct; 15(10):384-95. PubMed ID: 24105820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology.
    Li L; Yi H; Liu Z; Long P; Pan T; Huang Y; Li Y; Li Q; Ma Y
    Stem Cell Res Ther; 2022 Mar; 13(1):102. PubMed ID: 35255977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells.
    Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB
    Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors.
    Chupradit K; Thongsin N; Tayapiwatana C; Wattanapanitch M
    PLoS One; 2022; 17(7):e0270963. PubMed ID: 35797389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted biallelic integration of an inducible Caspase 9 suicide gene in iPSCs for safer therapies.
    Wunderlich S; Haase A; Merkert S; Jahn K; Deest M; Frieling H; Glage S; Korte W; Martens A; Kirschning A; Zeug A; Ponimaskin E; Göhring G; Ackermann M; Lachmann N; Moritz T; Zweigerdt R; Martin U
    Mol Ther Methods Clin Dev; 2022 Sep; 26():84-94. PubMed ID: 35795779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan 3D cell culture system promotes naïve-like features of human induced pluripotent stem cells: A novel tool to sustain pluripotency and facilitate differentiation.
    Chang PH; Chao HM; Chern E; Hsu SH
    Biomaterials; 2021 Jan; 268():120575. PubMed ID: 33341735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
    Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
    PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.